Literature DB >> 11786675

Lower urinary tract symptoms: what are the implications for the patients?

R M Scarpa1.   

Abstract

Patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) complain about symptoms such as weak stream, dribbling, intermittency, frequency, nocturia and urgency. To effectively manage these symptoms, it is important to better understand the epidemiology and/or the bothersomeness of these symptoms, the impact of the symptoms on the patient's quality of life and life style, when and why patients seek medical advice and the subsequent management of LUTS/BPH in clinical practice. This paper gives an overview of these issues considering 3 recently conducted European surveys. Although voiding symptoms are more frequent in patients with LUTS/BPH, storage symptoms, such as frequency, urgency, nocturia and urge incontinence, seem to be more bothersome to the patients. LUTS seem to have a negative impact on the patient's quality of life and sexuality and to interfere strongly with daily life activities. With regard to sexuality, interference with the patient's overall sex life and erection problems is experienced as much more bothersome than ejaculation problems. After the initial symptoms, most patients postpone a visit to the physician and try to adjust their life style to self manage their symptoms. Eventually they seek medical advice because they are too much bothered by their LUTS. In Italy, medical therapy is the most frequently administered treatment option by urologists (57% of patients) followed by surgery (37% of patients). alpha(1)-Adrenoceptor antagonists are the predominant medical therapy prescribed (70% of all medically treated patients), particularly tamsulosin (35% of all medically treated patients). An interview with European urologists confirms that alpha(1)-adrenoceptor antagonists, especially newer uro-selective ones like tamsulosin, are a very appropriate initial treatment choice in the management of both voiding and storage LUTS. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11786675     DOI: 10.1159/000049890

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  11 in total

1.  Lower urinary tract symptoms in men.

Authors:  Christopher R Chapple; Anand K Patel
Journal:  BMJ       Date:  2007-01-06

Review 2.  The efficacy and safety of silodosin in treating BPH: a systematic review and meta-analysis.

Authors:  Yuanshan Cui; Huantao Zong; Yong Zhang
Journal:  Int Urol Nephrol       Date:  2012-08-24       Impact factor: 2.370

Review 3.  Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).

Authors:  S Ventura; V l Oliver; C W White; J H Xie; J M Haynes; B Exintaris
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

4.  Health seeking behavior for lower urinary tract symptoms in black men.

Authors:  Aruna V Sarma; Lauren Wallner; Steven J Jacobsen; Rodney L Dunn; John T Wei
Journal:  J Urol       Date:  2008-05-21       Impact factor: 7.450

5.  Effect of once-daily alfuzosin on urinary symptoms and flow rate in benign prostatic hyperplasia : a 24-hour home-uroflowmetry evaluation.

Authors:  Cosimo De Nunzio; Giorgio Franco; Costantino Leonardo; Alberto Trucchi; Andrea Tubaro; Cesare Laurenti
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  In a free healthcare system, why do men not consult for lower urinary tract symptoms (LUTS)?

Authors:  U Chong Lai; Yuk Tsan Wun; Tze Chao Luo; Sai Meng Pang
Journal:  Asia Pac Fam Med       Date:  2011-06-08

7.  Terminal dribbling in male patients with lower urinary tract symptoms: relationship with International Prostate Symptom Score and with intravesical prostatic protrusion.

Authors:  Jae Heon Kim; Ji Sung Shim; Hoon Choi; Du Geon Moon; Jeong Gu Lee; Je Jong Kim; Jae Hyun Bae; Jae Young Park
Journal:  BMC Urol       Date:  2015-08-29       Impact factor: 2.264

8.  Nocturia in Patients With Parkinson's Disease.

Authors:  Matthew Smith; Jai Seth; Amit Batla; Johann Hofereiter; Kailash P Bhatia; Jalesh N Panicker
Journal:  Mov Disord Clin Pract       Date:  2015-12-24

Review 9.  Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?

Authors:  Amit Batla; Véronique Phé; Lorenzo De Min; Jalesh N Panicker
Journal:  Mov Disord Clin Pract       Date:  2016-06-07

10.  Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study.

Authors:  Claus G Roehrborn; Igor Oyarzabal Perez; Erik P M Roos; Nicolae Calomfirescu; Betsy Brotherton; Juan Manuel Palacios; Averyan Vasylyev; Michael J Manyak
Journal:  World J Urol       Date:  2016-06-22       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.